- Home
- VRCA vs SPAI Comparison
VRCA vs SPAI Comparison
Compare VRCA & SPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- SPAI
- Stock Information
- Founded
- VRCA 2013
- SPAI 2021
- Country
- VRCA United States
- SPAI United States
- Employees
- VRCA N/A
- SPAI N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- SPAI Industrial Specialties
- Sector
- VRCA Health Care
- SPAI Health Care
- Exchange
- VRCA Nasdaq
- SPAI Nasdaq
- Market Cap
- VRCA 58.0M
- SPAI 51.7M
- IPO Year
- VRCA 2018
- SPAI 2024
- Fundamental
- Price
- VRCA $0.72
- SPAI $2.36
- Analyst Decision
- VRCA Hold
- SPAI
- Analyst Count
- VRCA 5
- SPAI 0
- Target Price
- VRCA $6.00
- SPAI N/A
- AVG Volume (30 Days)
- VRCA 416.0K
- SPAI 306.4K
- Earning Date
- VRCA 02-27-2025
- SPAI 11-14-2024
- Dividend Yield
- VRCA N/A
- SPAI N/A
- EPS Growth
- VRCA N/A
- SPAI N/A
- EPS
- VRCA N/A
- SPAI N/A
- Revenue
- VRCA $9,210,000.00
- SPAI $1,559,057.00
- Revenue This Year
- VRCA $64.32
- SPAI N/A
- Revenue Next Year
- VRCA $73.76
- SPAI N/A
- P/E Ratio
- VRCA N/A
- SPAI N/A
- Revenue Growth
- VRCA 187.45
- SPAI 35.50
- 52 Week Low
- VRCA $0.61
- SPAI $1.56
- 52 Week High
- VRCA $11.41
- SPAI $6.50
- Technical
- Relative Strength Index (RSI)
- VRCA 46.69
- SPAI N/A
- Support Level
- VRCA $0.68
- SPAI N/A
- Resistance Level
- VRCA $0.75
- SPAI N/A
- Average True Range (ATR)
- VRCA 0.06
- SPAI 0.00
- MACD
- VRCA 0.02
- SPAI 0.00
- Stochastic Oscillator
- VRCA 75.35
- SPAI 0.00
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About SPAI Safe Pro Group Inc. Common Stock
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Safe-Pro USA.